Back to search

Peptide record

TPDB24366

Longicalycinin A linear analogue 7 Antibacterial Anticancer Toxicity standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB24366
Longicalycinin A linear analogue 7
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 5-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
Sequence
PYVFA
Physicochemical Analysis
C31H41N5O7
RNDCEQGHILKMSTW
AFPYV
595.70
5.94
0
0
4
-0
-1.72
1.180
78.00
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
1490
250.13
1
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
1
F
1
P
0
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 1 S: 0 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
5
C31H41N5O7
595.70
5.94
-0
-1.72
1.180
Free
L
Linear
Free
Anticancer
Synthetic Analogue of Longicalycinin A
Evidence Records 7 records
Evidence 1 Activity

Activity

IC50
IC50 = 9.6 ± 0.0007 µg/ml
Anticancer
9.6

Target

Liver Cancer
HepG-2
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 9.78 ± 0.0212 µg/ml
Anticancer
9.78

Target

Colorectal Cancer
HT-29
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
Evidence 3 Activity

Activity

82.33% Cell death at 100 µg/ml
Anticancer

Target

Liver Cancer
HepG-2
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
Evidence 4 Activity

Activity

84.17% Cell death at 100 µg/ml
Anticancer

Target

Colorectal Cancer
HT-29
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
Evidence 5 Activity

Activity

59.34% Cell death
Toxicity
100 µg/mL
Cytotoxic
59.34% Cell death | 100 | µg/mL | target cell: Human skin fibroblasts

Target

Human skin fibroblasts

Source & Reference

NA
DBAASP
Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides. | Chem Biol Interact | 2020
Evidence 6 Activity

Activity

43.52% Hemolysis
Toxicity
100 µg/mL
Cytotoxic
43.52% Hemolysis | 100 | µg/mL | target cell: Human skin fibroblasts

Target

Human skin fibroblasts

Source & Reference

NA
DBAASP
Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides. | Chem Biol Interact | 2020
Evidence 7 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Chem Biol Interact. 2020 Jan 5 315:108906.